CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,514 enrolled
Drug / intervention
Admission to a novel hospital wardother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00563186
NCT00563186N/ACompleted

Physical Plant Design and Engineering Controls and the Prevention of Nosocomial Infections and Antibiotic Resistant Organism Colonization Events - A Proposal for a Prospective Controlled Trial

University of Calgary·interventional·Posted Nov 26, 2007·Updated Oct 23, 2018

In Brief

A clinical study evaluating Admission to a novel hospital ward for Vancomycin Resistant Enterococci Infection and 3 related conditions. Completed, enrolled 1,514 participants across 1 site.

Detailed Summary

With the construction of a new medical teaching ward with features designed to reduce hospital-acquired infections, we hypothesized that the design of the new ward was the major factor that contributed to the improved outcomes and designed a prospective, controlled study to examine this hypothesis.

Study Details

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 26, 2007
Enrollment StartJun 1, 2007
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 18.6 years ago

Interventions

Admission to a novel hospital wardother

Hospital admission to a ward with novel infection control design features (e.g., abundance of sinks, predominance (80%) of private rooms, absence of shared bathrooms, absence of curtains)